dc.contributor.author | Melek Bilgin | |
dc.contributor.author | Tuba Yıldırım | |
dc.contributor.author | Murat Hökelek | |
dc.date.accessioned | 09.07.201910:49:13 | |
dc.date.accessioned | 2019-07-09T21:05:27Z | |
dc.date.available | 09.07.201910:49:13 | |
dc.date.available | 2019-07-09T21:05:27Z | |
dc.date.issued | 2013 | |
dc.identifier.issn | 2146-3123 | |
dc.identifier.uri | https://app.trdizin.gov.tr/publication/paper/detail/TVRZNE1EazVPUT09 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12450/248 | |
dc.description.abstract | Objective: Ivermectin and sulphadiazine were tested individually to determine their in vitro effects on Toxoplasma gondii grown in human epidermoid larynx carcinoma (Hep-2) cell culture. Study Design: In-vitro study. Material and Methods: Toxoplasma growth was quantities by an enzyme immunoassay performed directly on the fixed cultures, using a rabbit anti-T. gondii immunoglobulin G as the first antibody and a phosphatase-labeled anti-rabbit immunoglobulin G as the second antibody. For each drug, regres- sion models were used to quantify the relationship between optical density values and antimicrobial agent concentrations in the cultures. Results: The 50% inhibitory concentrations (IC50) of ivermectin and sulphadiazine were found to be 0.2 μg/mL and 7.3 μg/mL after 48 h of exposure, respectively. None of the concentrations tested for each drugs demonstrated toxicity to Hep-2 cells after 72 h of incubation. Conclusion: These results indicate that ivermectin significantly inhibited replication of the tachyzoites of T. gondii RH strain. | en_US |
dc.description.abstract | Objective: Ivermectin and sulphadiazine were tested individually to determine their in vitro effects on Toxoplasma gondii grown in human epidermoid larynx carcinoma (Hep-2) cell culture. Study Design: In-vitro study. Material and Methods: Toxoplasma growth was quantities by an enzyme immunoassay performed directly on the fixed cultures, using a rabbit anti-T. gondii immunoglobulin G as the first antibody and a phosphatase-labeled anti-rabbit immunoglobulin G as the second antibody. For each drug, regres- sion models were used to quantify the relationship between optical density values and antimicrobial agent concentrations in the cultures. Results: The 50% inhibitory concentrations (IC50) of ivermectin and sulphadiazine were found to be 0.2 μg/mL and 7.3 μg/mL after 48 h of exposure, respectively. None of the concentrations tested for each drugs demonstrated toxicity to Hep-2 cells after 72 h of incubation. Conclusion: These results indicate that ivermectin significantly inhibited replication of the tachyzoites of T. gondii RH strain. | en_US |
dc.language.iso | eng | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Cerrahi | en_US |
dc.title | In vitro effects of ıvermectin and sulphadiazine on toxoplasma gondii | en_US |
dc.type | article | en_US |
dc.relation.journal | Balkan Medical Journal | en_US |
dc.department | Amasya Üniversitesi | en_US |
dc.identifier.volume | 30 | en_US |
dc.identifier.issue | 1 | en_US |
dc.identifier.startpage | 19 | en_US |
dc.identifier.endpage | 22 | en_US |
dc.relation.publicationcategory | Makale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı | en_US |